Skip to main content
logo
Chandra Bhagat Pharma Limited (BOM:542934)
India flag India · Delayed Price · Currency is INR
39.36
+1.86 (4.96%)
At close: Aug 4, 2026

Chandra Bhagat Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,1631,163887.672,2251,197940.76
Revenue Growth
135.39%30.99%-60.10%85.93%27.21%33.07%
Gross Profit
227.09227.09152.86142.31129.04126.34
Operating Income
61.0861.0822.2431.6936.6651.17
Net Income
30.4630.468.5815.39.057.97
Earnings Per Share
4.044.041.142.031.201.06
EPS Growth
388.72%255.35%-43.95%69.02%13.64%322.37%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
47.7947.798.0250.9765.4959.03
Total Debt
165.07165.07208.6164.27189.45211.18
Net Cash (Debt)
-117.28-117.28-200.58-113.3-123.95-152.15
Net Cash Growth
------
Net Cash Per Share
-15.55-15.55-26.58-15.02-16.43-20.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
92.3692.36-55.8261.7652.64123.98
Capital Expenditures
-9.21-9.21-12.03-22.82-3.69-1
Free Cash Flow
83.1583.15-67.8438.9448.96122.99
Free Cash Flow Growth
479.45%---20.46%-60.19%48.03%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
19.53%19.53%17.22%6.40%10.78%13.43%
Operating Margin
5.25%5.25%2.50%1.42%3.06%5.44%
Pretax Margin
3.53%3.53%1.35%1.15%1.18%1.17%
Profit Margin
2.62%2.62%0.97%0.69%0.76%0.85%
FCF Margin
7.15%7.15%-7.64%1.75%4.09%13.07%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
9.747.5646.0346.8480.83107.77
P/FCF Ratio
3.572.77-18.4114.956.98
PS Ratio
0.260.200.450.320.610.91